Bora Nam1, Bon San Koo2, Seoung Wan Nam3, Ji-Hui Shin1, Yoonah Song4, Soo-Kyung Cho1, Yoon-Kyoung Sung1, Tae-Hwan Kim5. 1. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea. 2. Department of Rheumatology, Inje University Seoul Paik Hospital, Seoul, Republic of Korea. 3. Department of Rheumatology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea. 4. Department of Radiology, Kok Hospital, Gyeonggi-do, Republic of Korea. 5. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea. thkim@hanyang.ac.kr.
Abstract
PURPOSE: To identify predictors of low health-related quality of life (HRQoL) and depression in ankylosing spondylitis (AS) patients with a focus on gender differences. METHODS: We conducted a cross-sectional cohort study. Both AS-related clinical data and contextual factors were obtained. HRQoL and depressive mood were assessed by EuroQol-5 dimension (EQ-5D) and the Center for Epidemiological Studies Depression Scale (CES-D), respectively. Gender-stratified multivariable logistic regression analyses were performed. RESULTS: Among 211 patients, 161 were males. Males had similar disease activity and higher radiographic damage compared with females. There was no significant difference in EQ-5D index score between genders. CES-D score was higher in females. Higher ASDAS-C-reactive protein (CRP) was associated with low HRQoL in both males (Odds ratio [OR] 4.25, 95% confidence interval [CI] 2.42-7.46) and females (OR 2.94, 95% CI 1.02-8.48). Being employed was associated with decreased possibility of having low HRQoL in males (OR 0.39, 95% CI 0.16-0.95). Regarding depression, higher ASDAS-CRP (OR 1.87, 95% CI 1.03-3.40), current smoking (OR 2.98, 95% CI 1.09-8.15), and being employed (OR 0.17, 95% CI 0.06-0.46) were associated with depression in males. For females, living with a partner was related to depression (OR 0.08, 95% CI 0.01-0.93). CONCLUSION: AS patients with high disease activity are likely to be suffering from low HRQoL. Both disease-related factors and contextual factors were associated with depression, and predictors showed some differences between genders. Awareness of gender differences in comprehensive assessment can lead us to better personalized management in AS patients.
PURPOSE: To identify predictors of low health-related quality of life (HRQoL) and depression in ankylosing spondylitis (AS) patients with a focus on gender differences. METHODS: We conducted a cross-sectional cohort study. Both AS-related clinical data and contextual factors were obtained. HRQoL and depressive mood were assessed by EuroQol-5 dimension (EQ-5D) and the Center for Epidemiological Studies Depression Scale (CES-D), respectively. Gender-stratified multivariable logistic regression analyses were performed. RESULTS: Among 211 patients, 161 were males. Males had similar disease activity and higher radiographic damage compared with females. There was no significant difference in EQ-5D index score between genders. CES-D score was higher in females. Higher ASDAS-C-reactive protein (CRP) was associated with low HRQoL in both males (Odds ratio [OR] 4.25, 95% confidence interval [CI] 2.42-7.46) and females (OR 2.94, 95% CI 1.02-8.48). Being employed was associated with decreased possibility of having low HRQoL in males (OR 0.39, 95% CI 0.16-0.95). Regarding depression, higher ASDAS-CRP (OR 1.87, 95% CI 1.03-3.40), current smoking (OR 2.98, 95% CI 1.09-8.15), and being employed (OR 0.17, 95% CI 0.06-0.46) were associated with depression in males. For females, living with a partner was related to depression (OR 0.08, 95% CI 0.01-0.93). CONCLUSION: AS patients with high disease activity are likely to be suffering from low HRQoL. Both disease-related factors and contextual factors were associated with depression, and predictors showed some differences between genders. Awareness of gender differences in comprehensive assessment can lead us to better personalized management in AS patients.
Authors: Astrid van Tubergen; Sofia Ramiro; Désirée van der Heijde; Maxime Dougados; Herman Mielants; Robert Landewé Journal: Ann Rheum Dis Date: 2011-10-11 Impact factor: 19.103
Authors: Sofia Ramiro; Carmen Stolwijk; Astrid van Tubergen; Désirée van der Heijde; Maxime Dougados; Filip van den Bosch; Robert Landewé Journal: Ann Rheum Dis Date: 2013-08-16 Impact factor: 19.103
Authors: Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman Journal: Ann Rheum Dis Date: 2006-11-24 Impact factor: 19.103
Authors: Bernd Löwe; Levke Willand; Wolfgang Eich; Stephan Zipfel; Anthony D Ho; Wolfgang Herzog; Christoph Fiehn Journal: Psychosom Med Date: 2004 May-Jun Impact factor: 4.312
Authors: Antonio Filipe Macedo; Amanda Hellström; Robert Massof; Hanna Tuvesson; Mikael Rask; Pedro Lima Ramos; Jalal Safipour; Ina Marteinsdottir; Evalill Nilsson; Cecilia Fagerström; Kristofer Årestedt Journal: Health Qual Life Outcomes Date: 2022-09-06 Impact factor: 3.077